Chemed (CHE) Projected to Post Quarterly Earnings on Wednesday

Chemed (NYSE:CHE) will likely be issuing its quarterly earnings data after the market closes on Wednesday, February 26th. Analysts expect the company to announce earnings of $6.78 per share and revenue of $636.10 million for the quarter. Parties that wish to listen to the company’s conference call can do so using this link.

Chemed Price Performance

CHE stock opened at $544.75 on Monday. The business has a fifty day moving average price of $542.60 and a 200 day moving average price of $563.67. Chemed has a fifty-two week low of $512.12 and a fifty-two week high of $654.62. The stock has a market capitalization of $8.20 billion, a price-to-earnings ratio of 27.53, a P/E/G ratio of 2.15 and a beta of 0.48.

Chemed Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, March 14th. Stockholders of record on Monday, February 24th will be paid a $0.50 dividend. The ex-dividend date of this dividend is Monday, February 24th. This represents a $2.00 annualized dividend and a dividend yield of 0.37%. Chemed’s dividend payout ratio (DPR) is currently 10.11%.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on CHE. Royal Bank of Canada decreased their price objective on Chemed from $697.00 to $633.00 and set an “outperform” rating for the company in a research note on Tuesday, November 5th. StockNews.com upgraded Chemed from a “hold” rating to a “buy” rating in a report on Saturday, November 30th.

Insider Activity

In other news, EVP Spencer S. Lee sold 732 shares of the company’s stock in a transaction that occurred on Wednesday, November 27th. The stock was sold at an average price of $575.62, for a total value of $421,353.84. Following the transaction, the executive vice president now owns 18,287 shares of the company’s stock, valued at approximately $10,526,362.94. This represents a 3.85 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, VP Brian C. Judkins purchased 145 shares of the business’s stock in a transaction that occurred on Monday, December 30th. The stock was bought at an average price of $519.50 per share, with a total value of $75,327.50. Following the completion of the purchase, the vice president now owns 1,678 shares of the company’s stock, valued at $871,721. This trade represents a 9.46 % increase in their position. The disclosure for this purchase can be found here. 3.32% of the stock is owned by company insiders.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.